Chimeric Therapeutics is trading at A$0.01, down -12.50% on September 14, 2026, with no confirmed direct catalyst identified.
- No clearly relevant company-specific announcement was identified on September 14 or the preceding session; the latest indexed filing was a September 4 securities-quotation notice.
- Major U.S. indices were flat, while recent sharp daily swings and the stock’s very low price suggest illiquid, volatile trading.